Incorporating initial treatments improves performance of a mortality prediction model for patients with sepsis.
Pharmacoepidemiol Drug Saf., May;21 Suppl 2:44-52 (2012)
What is the best method for estimating the burden of severe sepsis in the United States?
J Crit Care., Aug;27(4):414.e1-9 (2012)
A phase I study evaluating the pharmacokinetics, safety and tolerability of an antibody-based tissue factor antagonist in subjects with acute lung injury or acute respiratory distress syndrome.
BMC Pulm Med., 12:5 (2012)
Variation in the care of septic shock: the impact of patient and hospital characteristics.
J Crit Care., Aug;27(4):329-36 (2012)
Development and validation of a model that uses enhanced administrative data to predict mortality in patients with sepsis.
Crit. Care Med., Nov;39(11):2425-30 (2011)
Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007.
Crit. Care Med., Mar;40(3):754-61 (2012)
Acute kidney injury in patients with acute lung injury: impact of fluid accumulation on classification of acute kidney injury and associated outcomes.
Crit. Care Med., Dec;39(12):2665-71 (2011)
Vascular pedicle width in acute lung injury: correlation with intravascular pressures and ability to discriminate fluid status.
Crit Care., 15(2):R86 (2011)
The relationship between hospital spending and mortality in patients with sepsis.
Arch. Intern. Med., Feb;171(4):292-9 (2011)
A prospective, observational study of Xigris Use in the United States (XEUS).
J Crit Care., Dec;25(4):660.e9-16 (2010)
Activated protein C and hospital mortality in septic shock: a propensity-matched analysis.
Crit. Care Med., Apr;38(4):1101-7 (2010)
Multicenter, randomized, placebo-controlled study of the nitric oxide scavenger pyridoxalated hemoglobin polyoxyethylene in distributive shock.
Crit. Care Med., Jul;36(7):1999-2007 (2008)
Multicenter validation of a computer-based clinical decision support tool for glucose control in adult and pediatric intensive care units.
J Diabetes Sci Technol., May;2(3):357-68 (2008)
Adding up the zeros.
J Intensive Care Med., 21(3):188-90 (2006 May-Jun)
Drotrecogin alfa (activated) in sepsis: initial experience with patient selection, cost, and clinical outcomes.
J Intensive Care Med., 20(6):339-45 (2005 Nov-Dec)
Pregnancy-associated severe liver dysfunction.
Crit Care Clin., Oct;20(4):763-76, xi (2004)
Hemodynamic consequences of heart-lung interactions.
J Intensive Care Med., 18(2):92-9 (2003 Mar-Apr)
Steroids and drotrecogin alfa (activated) for severe sepsis.
Chest., Nov;124(5):2033 (2003)
Blood glucose and neurologic outcome with global brain ischemia.
Crit. Care Med., May;24(5):802-6 (1996)
Therapeutic impact of pulmonary artery catheterization in a medical/surgical ICU.
Chest., Jun;99(6):1451-5 (1991)